VCP International Scientific Conference 2024 | Cure VCP Disease | 22 February 2024 | Caltech, Pasadena, California, 1200 E California Blvd, Pasadena, CA 91125, USA

Since our 2021 virtual Scientific Conference, the field of VCP disease research has progressed rapidly. There is now an urgent need for researchers to meet, exchange knowledge, and set the agenda for future pre-clinical and translational research. The conference will bring scientists, clinicians, and patient advocates together. Join and dive into enlightening sessions, meet event chairs, explore our sponsors, and be part of groundbreaking discussions in VCP disease research. The conference is intended to take an integrated approach across diseases. We will gather data in the VCP genetic form of muscular and neurodegenerative disorders that contribute to multiple phenotypes, offering clues to benefit a large number of patients, i.e. ALS and FTD overlaps.

2024 Speakers

Ray Deshaies
Senior Vice President, Global Research, Amgen

Margherita Milone
Professor of Neurology, Mayo Clinic

Tsui-Fen Chou
Research Professor in Biology, Caltech

Lindsay Alfano
Principal Investigator, The Abigail Wexner Research Institute at Nationwide Children’s Hospital

Dan Anderson
Chief Scientific Officer, Eikon Therapeutics

Michelle Arkin
Department Chair, Department of Pharmaceutical Chemistry, University of California, San Francisco

Ganesh Babulal
Associate Professor of Neurology, Washington University in St. Louis

Eleonora D'Ambrosio
Gene Therapy Fellow, Nationwide Children's Hospital

Jordi Diaz-Manera
Professor of Neuromuscular, Translational Medicine and Genetics, John Walton Muscular Dystrophy Research Centre, Newcastle University

Jaquelin Dudley
Professor, LaMontagne Center for Infectious Disease, The University of Texas at Austin

Nupur Ghoshal
Professor of Neurology and Psychiatry, Washington University

Donna Huryn
Professor of Practice, University of Pennsylvania

Alyssa Johnson
Assistant Professor, Louisiana State University

Kevin Jones
Professor, Department of Orthopaedics, University of Utah

Virginia Kimonis
MD, University of California, Irvine

Evangelos Kiskinis
Assistant Professor of Neurology, Northwestern University

Edward Lee
Associate Professor, University of Pennsylvania

Tom Lloyd
Chair and Professor of Neurology, Baylor College of Medicine

Mark Mapstone
Professor of Neurology, University of California, Irvine

Andreas Martin
Associate Professor, University of California, Berkeley

Hemmo Meyer
Faculty of Biology, University of Duisburg-Essen, Center of Medical Biotechnology (ZMB)

Tahseen Mozaffar
Professor, Neurology, University of California-Irvine School of Medicine

Gerald Pfeffer
Assistant Professor, UCalgary

Armelle Pindon
Chief Scientific Officer, Cure VCP Disease, Inc.

Malavika Raman
Associate Professor, Tufts University School of Medicine

Isabelle Richard
Director of Research CNRS Class 1, Genethon

David Rubinsztein
Professor of Molecular Neurogenetics, Cambridge Institute for Medical Research

Marianela Schiava
Clinical Research Associate, John Walton Musuclar Dystrophy Centre

Anne Schuetz
Professor, Department of Chemistry, Ludwig-Maximilians-Universität Munich

Peter Shen
Assistant Professor, University of Utah

Daniel Southworth
Professor, University of California, San Francisco

Adam Staffaroni
Assistant Professor at UCSF Memory and Aging Center, University of California San Francisco

Maja Tarailo-Graovac
Associate Professor, Department of Biochemistry & Molecular Biology, University of Calgary

Conrad Weihl
Professor of Neurology, Washington University School of Medicine in St. Louis

Qingping Yao
Professor, Department of Medicine, Stony Brook University, Renaissance School of Medicine

Yihong Ye
Senior Investigator, NIH, NIDDK, Laboratory of Molecular Biology

2024 Sponsors

VISIONARY LEVEL SPONSORS:
• Cure VCP Disease, Inc.
• Muscular Dystrophy Association
• Chan Zuckerberg Initiative Rare As One Project

CHAMPION LEVEL SPONSORS:
• The Association for Frontemporal Degeneration

PARTNER LEVEL SPONSORS:
• Eikon Therapeutics

ALLY LEVEL SPONSORS:
• Extravega Architectural Fabrications